Press Releases
Adocia launches phase IIa clinical trial for its ultra-fast...
Adocia , a biotechnology company specialized in the development of ‘best-in-class’ medicines from already approved therapeutic proteins, in particular proteins and oncologic treatments, launches today...
Press Releases
Domain Therapeutics, Universite de Montreal, IRICoR and McGill University...
Domain Therapeutics, a France-based biopharmaceutical company that specializes in the research and development of new drug candidates that target G-protein coupled receptors (GPCRs), is pleased...
Press Releases
Biosimilars & Biobetters USA – Industry leaders will meet...
Creating an Innovate Plan for the USA Biosimilars Market: presentations from Sandoz, IMS Health, Bristows, PRA International, Celltrion, MedImmune, Novartis, Lonza Biologics and others. ...
Press Releases
Eureka Science proudly announces the collaboration with international societies...
Eureka Science proudly announces the collaboration with international societies and organizations for the events; the “6th International Conference on Drug Discovery and Therapy” and the...
Press Releases
FibroGen Announces Analysis of Peritoneal Dialysis Patients With Chronic...
FibroGen Inc. (FibroGen) today announced the presentation of a Phase 2 subgroup analysis comparing treatment response to roxadustat (FG-4592) a first-in-class oral compound in late...
Press Releases
Oncodesign and UCB enter into a research collaboration for...
The partnership is based on Oncodesign's Nanocyclix(R) technology platform for next generation kinase inhibitors and UCB’s expertise in neurology. Oncodesign, a...
Press Releases
Adocia announces the initiation of a clinical trial on...
This phase I/II clinical trial on Type I Diabetics seeks to compare the performance of this Combo based on insulin Glargine with HumalogMix(R). ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.